Business
Eli Lilly Q3 Revenue Jumps 39% to $24.4 Billion, but the Price It Realized Fell 15%
Eli Lilly's third-quarter revenue rose 39% to $24.4 billion and the company raised its 2026 forecast, but volume rose 53% while the price it realized fell 15%.